Lung cancer (small-cell, second line treatment) - topotecan: evaluation report
Lung cancer (small-cell, second line treatment) - topotecan: overview
Lung cancer (small-cell, second line treatment) - topotecan: assessment report
Lung cancer (small-cell, second line treatment) - topotecan: Consultee and commentator comments on the assessment report
Lung cancer (small-cell, second line treatment) - topotecan: Assessment Group response to manufacturer comments on the Assessment Report
Lung cancer (small-cell, second line treatment) - topotecan: Non-manufacturer submissions
Lung cancer (small-cell, second line treatment) - topotecan: Manufacturer submission
Lung cancer (small-cell, second line treatment) - topotecan: Expert written personal statements
This page was last updated: 30 March 2010